CG
REGN icon

Cutler Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Cutler Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,100
Closed -$20K – 5063
2022
Q3 		$20K Sell
1,100
-3,500
-76% -$2.2M ﹤0.01% 2626
2022
Q2 		$36K Buy
4,600
+900
+24% +$585K ﹤0.01% 2205
2022
Q1 		$108K Buy
+3,700
New +$2.34M 0.01% 1636
2019
Q1 		– Sell
-14,100
Closed -$108K – 4627
2018
Q4 		$108K Buy
14,100
+11,000
+355% +$4.03M 0.01% 978
2018
Q3 		$149K Hold
3,100
– – 0.01% 989
2018
Q2 		$99K Sell
3,100
-8,000
-72% -$2.5M 0.01% 1154
2018
Q1 		$176K Buy
11,100
+1,900
+21% +$661K 0.02% 886
2017
Q4 		$191K Sell
9,200
-9,900
-52% -$4.01M 0.01% 991
2017
Q3 		$768K Sell
19,100
-10,900
-36% -$5.19M 0.03% 445
2017
Q2 		$1.3M Buy
30,000
+26,600
+782% +$11.6M 0.05% 332
2017
Q1 		$69K Sell
3,400
-2,600
-43% -$964K ﹤0.01% 2079
2016
Q4 		$82K Buy
6,000
+5,000
+500% +$1.9M ﹤0.01% 2088
2016
Q3 		$35K Sell
1,000
-300
-23% -$120K ﹤0.01% 2821
2016
Q2 		$24K Sell
1,300
-100
-7% -$38.5K ﹤0.01% 3159
2016
Q1 		$32K Sell
1,400
-7,500
-84% -$3.09M ﹤0.01% 2784
2015
Q4 		$271K Buy
+8,900
New +$4.82M 0.02% 945

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cutler Group's REGN Position: Q4 2022 in Review

Cutler Group sold out of Regeneron Pharmaceuticals (REGN) in Q4 2022, closing a stake of 700 shares — an estimated $482K sold.

Cutler Group first reported a position in REGN in Q4 2015 and held it in 13 quarters. The position peaked at $2.06M in Q4 2017. 1,159 funds tracked by Wall St. Rank hold REGN as of Q4 2022.

  • Cutler Group reported no remaining Regeneron Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 700 Regeneron Pharmaceuticals shares in Q4 2022, an estimated $482K.
  • Cutler Group first reported a position in Regeneron Pharmaceuticals in Q4 2015 and held it in 13 quarters.
  • Cutler Group's Regeneron Pharmaceuticals position peaked at $2.06M in Q4 2017.
  • 1,159 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.